Prostate treatment in the Middle East / Lebanon
Dr. Fouad Khoury discussing the most innovative prostate surgeries including minimally invasive transurethral water vapor therapy (Known as REZUM).
Benefits of water vapor therapy :
– 5 to 10 minutes procedure
-Preservation of ejaculation
-Preservation of sexual function
– Done under local anesthesia
– Same day procedure
-return to daily activities in a few days
-a good prognosis of up to 15 years
Follow the link for more detailed information about REZUM therapy in Lebanon and the Middle East
What Rezum actually does
Rezum treats benign prostatic hyperplasia, the non-cancerous enlargement of the prostate that obstructs urine flow. A small needle delivers a few seconds of sterile water vapour into the overgrown tissue. The steam releases its stored energy into the cells, which then die and are reabsorbed by the body over the following weeks. Because the effect is confined to the tissue treated, the nerves and muscle responsible for continence and ejaculation are usually left intact.
Who is a suitable candidate
Rezum tends to suit men with moderate obstructive symptoms who want to stop taking daily medication, and men who particularly want to preserve ejaculatory function. Prostate size, the presence of a middle lobe, bladder function and general health all influence whether it is appropriate. Assessment normally includes a flow study, an ultrasound measurement of residual urine and a PSA test.
An honest account of recovery
Symptoms usually get worse before they get better. Urgency, frequency and burning are common in the first one to two weeks, and a catheter is often needed for several days while the swelling settles. Meaningful improvement typically appears around four to six weeks and continues to build for about three months. A minority of men need a further procedure later. Anyone describing Rezum as instant relief is not giving an accurate picture.
What Rezum does not treat
Rezum is a treatment for benign enlargement. It is not a treatment for prostate cancer, and it does not replace prostate cancer screening. Men being assessed for urinary symptoms should still have their cancer risk evaluated separately, because the two conditions can coexist.